Medical Equipment News

ANNOUNCEMENT NO. 320 8 October 2026 The Board of Directors of ChemoMetec A/S has decided to buy back own shares based on the authorisation granted at the Annual General Meeting on 8 October 2026....

MEDDELELSE NR. 320 8. oktober 2026 Bestyrelsen i ChemoMetec A/S har besluttet at tilbagekøbe egne aktier på baggrund af bemyndigelsen givet på den ordinære generalforsamling den 8. oktober 2026....

Echosens to Address GLP-1 Costs, Metabolic Health at SIIA National Conference 2026, Highlight Opportunities for Self-Insured Stakeholders & On-Site Clinics

ANNOUNCEMENT NO. 319 8 October 2026 The Annual General Meeting of ChemoMetec A/S was held on 8 October 2026 at 17:30 at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of...

MEDDELELSE NR. 319 8. oktober 2026 Den ordinære generalforsamling i ChemoMetec A/S blev afholdt den 8. oktober 2026 kl. 17.30 hos Nordsjællands KonferenceCenter. På generalforsamlingen blev...

Vascudyne's lab-grown coronary bypass vessel stays open two years after implant, per EACTS 2026 data, as its European CABG study completes enrollment.

ATLANTA, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator developing transformative fertility and non-surgical permanent birth control solutions designed...

HOUSTON, Oct. 08, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) of the...

BEDMINSTER, N.J., Oct. 08, 2026 (GLOBE NEWSWIRE) -- Retrieve Medical Holdings, Inc. (OTC: RMHI), developer of Retrieve Passport℠, today announced a marketing agreement with a major U.S. financial...

Spirair publishes six-month Vayu Study results for SeptAlign®: 63% NOSE score reduction with lasting relief a less-invasive, cartilage-preserving approach.